Detection of immune responses after immunotherapy in glioblastoma using PET and MRI

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

(2017) Benjamin M. Ellingson et al.   Neurotherapeutics

Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange

(2016) K. Leu et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Monitoring immune responses in the tumor microenvironment

(2016) Jennifer A Wargo et al.   CURRENT OPINION IN IMMUNOLOGY

Tumor antigen–specific T cells for immune monitoring of dendritic cell–treated glioblastoma patients

(2016) Isabelle Müller et al.   CYTOTHERAPY

[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity

(2016) Woosuk Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination

(2016) M. S. Hsu et al.   Cancer Immunology Research

Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging

(2015) Melissa N. McCracken et al.   JOURNAL OF CLINICAL INVESTIGATION

Current challenges in designing GBM trials for immunotherapy

(2015) Shiao-Pei Weathers et al.   JOURNAL OF NEURO-ONCOLOGY

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

(2015) Hideho Okada et al.   LANCET ONCOLOGY

Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas

(2014) Elena Karavaeva et al.   MOLECULAR IMAGING AND BIOLOGY

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

(2013) Robert M. Prins et al.   JOURNAL OF IMMUNOTHERAPY

Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial

(2013) Benjamin M. Ellingson et al.   RADIOLOGY

Cancer classification using the Immunoscore: a worldwide task force

(2012) Jérôme Galon et al.   Journal of Translational Medicine

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy

(2010) Robert M. Prins et al.   CLINICAL CANCER RESEARCH

Epithelial Uptake of [18F]1-(2′-Deoxy-2′-Arabinofuranosyl) Cytosine Indicates Intestinal Inflammation in Mice

(2010) Sarah Brewer et al.   GASTROENTEROLOGY

PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice

(2010) Evan Nair-Gill et al.   JOURNAL OF CLINICAL INVESTIGATION

Novel PET Probes Specific for Deoxycytidine Kinase

(2010) C. J. Shu et al.   JOURNAL OF NUCLEAR MEDICINE

Pseudoprogression and pseudoresponse in the treatment of gliomas

(2009) Dieta Brandsma et al.   CURRENT OPINION IN NEUROLOGY

In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

(2009) Franck Pagès et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab and chemotherapy for recurrent glioblastoma: A single-institution experience

(2009) P. L. Nghiemphu et al.   NEUROLOGY

Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography

(2009) Rachel E. Laing et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2′-deoxycytidine analog

(2008) Caius G Radu et al.   NATURE MEDICINE